AU3573893A - Coumarin derivatives and their analogues inhibiting cell proliferation and tumour growth, pharmaceutical compositions containing them and process for preparing same - Google Patents

Coumarin derivatives and their analogues inhibiting cell proliferation and tumour growth, pharmaceutical compositions containing them and process for preparing same

Info

Publication number
AU3573893A
AU3573893A AU35738/93A AU3573893A AU3573893A AU 3573893 A AU3573893 A AU 3573893A AU 35738/93 A AU35738/93 A AU 35738/93A AU 3573893 A AU3573893 A AU 3573893A AU 3573893 A AU3573893 A AU 3573893A
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
cell proliferation
compositions containing
tumour growth
inhibiting cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35738/93A
Inventor
Tamas Bajor
Agnes Balogh
Gyongyi Bokonyi
Aniko Horvath
Miklos Idei
Gyorgy Keri
Laszlo Orfi
Endre Tihanyi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biosignal Kutato Fejlesztokft Kft
Original Assignee
Biosignal Kutato Fejlesztokft Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosignal Kutato Fejlesztokft Kft filed Critical Biosignal Kutato Fejlesztokft Kft
Publication of AU3573893A publication Critical patent/AU3573893A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/64—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU35738/93A 1992-02-13 1993-02-12 Coumarin derivatives and their analogues inhibiting cell proliferation and tumour growth, pharmaceutical compositions containing them and process for preparing same Abandoned AU3573893A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9200438 1992-02-13
HU9200438A HUT63843A (en) 1992-02-13 1992-02-13 Process for producing new kumarin derivatives and their analogs inhibiting mammal cell proliferation and tumour growth, as well as pharmaceutical comkpositions comprising such compounds

Publications (1)

Publication Number Publication Date
AU3573893A true AU3573893A (en) 1993-09-03

Family

ID=10981341

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35738/93A Abandoned AU3573893A (en) 1992-02-13 1993-02-12 Coumarin derivatives and their analogues inhibiting cell proliferation and tumour growth, pharmaceutical compositions containing them and process for preparing same

Country Status (3)

Country Link
AU (1) AU3573893A (en)
HU (1) HUT63843A (en)
WO (1) WO1993016064A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5563280A (en) * 1994-07-25 1996-10-08 American Cyanamid Co. 4-Phenoxycoumarins as herbicidal agents
US5648378A (en) * 1995-06-07 1997-07-15 Research Corporation Technologies, Inc. 2-iminochromene derivatives as inhibitors of protein tyrosine kinase
FI20001593A (en) 2000-07-03 2002-01-04 Orion Yhtymo Oyj Coumarin derivatives having Comt enzyme inhibitory activity
FR2822379B1 (en) * 2001-03-20 2007-06-15 Sederma Sa COSMETIC AND DERMOPHARMACEUTICAL COMPOSITIONS CONTAINING UMBELLIFERONE
WO2003024950A1 (en) * 2001-09-12 2003-03-27 Institute Of Medicinal Molecular Design. Inc. Coumarin derivative
WO2003076423A1 (en) * 2002-03-12 2003-09-18 Ube Industries, Ltd. Method for preparing 6,7-dihydroxycoumarin-3-carboxy compound
CN1506359A (en) 2002-12-05 2004-06-23 �й�ҽѧ��ѧԺҩ���о��� Coumarin amide derivative and its prepn, medicinal composition and use
BRPI0404130A (en) * 2004-09-20 2006-05-02 Univ Rio De Janeiro substituted coumarins, process for producing such coumarins and compositions containing the same
AR059339A1 (en) 2006-02-09 2008-03-26 Chugai Pharmaceutical Co Ltd CUMARINE DERIVATIVES FOR PROLIFERATIVE DISORDERS OF CELLS, PHARMACEUTICAL COMPOSITION AND THERAPEUTIC AGENT CONTAINING THEM
EP2172198B1 (en) 2007-07-20 2014-04-16 Chugai Seiyaku Kabushiki Kaisha p27 PROTEIN INDUCER

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582217A (en) * 1978-02-27 1981-01-07 Teijin Ltd Penicillin derivatives medicines containing the same and process for producing the same
IL69998A0 (en) * 1983-01-03 1984-01-31 Miles Lab Disopyramide immunogens,antibodies prepared therefrom,labeled conjugates,and the use of such antibodies and labeled conjugates in immunoassays
AT394556B (en) * 1990-04-26 1992-05-11 Gerot Pharmazeutika Novel coumarin derivatives and process for their preparation
JP2624372B2 (en) * 1990-11-15 1997-06-25 宇部興産株式会社 Diarylmethoxypiperidine derivative

Also Published As

Publication number Publication date
HUT63843A (en) 1993-10-28
WO1993016064A1 (en) 1993-08-19
HU9200438D0 (en) 1992-04-28

Similar Documents

Publication Publication Date Title
AU8259691A (en) 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them
HUT70851A (en) Organic salts of n,n`-diacetyl-cystine, pharmaceutical compositions containing them and process for preparing them
AU1591792A (en) New dialkylenepiperidino compounds and their enantiomers, process for preparing them and pharmaceutical compositions containing them
HUT70411A (en) Antiparasitic avermectin derivatives, process for preparing them and pharmaceutical compositions containing them
AU646112B2 (en) N,O-sulphated heparosans, process for preparing them and pharmaceutical compositions containing them
HUT64734A (en) Anthraquinone-derivativdes, process for preparing them and pharmaceutical compositions containing them
AU1594892A (en) New benzopyran compounds, process for preparing these and pharmaceutical compositions containing them
ZA934037B (en) Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same.
HU9402292D0 (en) New baccatine-iii and 10-deacetyl-baccatine-iii derivatives, process for producing them and pharmaceutical compositions containing them as active component
AU6667290A (en) Pyridazine derivatives, process for their preparation and pharmaceutical compositions containing them
AU3573893A (en) Coumarin derivatives and their analogues inhibiting cell proliferation and tumour growth, pharmaceutical compositions containing them and process for preparing same
AU4352193A (en) Novel aminopropanol derivatives, pharmaceutical compositions containing them and process for preparing same
AU7324087A (en) New immunosuppressant cyclodepsipeptides, process for their preparation and pharmaceutical compositions containing them
AU8917891A (en) Poly-aminopyrrolecarboxamido derivatives, processes for their preparation and pharmaceutical compositions containing them
AU617929B2 (en) Novel steroid derivatives, pharmaceutical compositions containing them and process for preparing same
AU8808791A (en) New benzoselenazolinone compounds, process for preparing these and pharmaceutical compositions containing them
AU631261B2 (en) Novel pyridine derivatives, pharmaceutical compositions containing them and process for preparing same
HU9303376D0 (en) Process for producing alpha, omega-diaryl-alkane derivatives and pharmaceutical compositions containing them
AU5110290A (en) Novel steroid diols, pharmaceutical compositions containing them and process for preparing same
AU4756693A (en) 1-heteroarylazetidines and -pyrrolidines, process for their preparation and pharmaceutical compositions containing them
ZA919224B (en) Process for preparing taxane derivatives,new derivatives obtained and pharmaceutical compositions containing them
AU8972591A (en) Novel 15-nitro-2beta,3beta-dihydro- and 15-nitro-2beta,3beta,6,7-tetrahydrotabersonine derivatives, pharmaceutical compositions containing them and process for preparing same
AU6016490A (en) New oxazolopyridine derivatives, process for preparing them and pharmaceutical compositions containing them
HU905745D0 (en) New oligopeptones selectively inhibiting proliferation of hemopoiethic cells, pharmaceutical preparatives containing these compounds as well as processes for producing these oligopeptones and preparatives
ZA903008B (en) Macrolide derivatives,process for preparing them and pharmaceutical compositions containing them